Litron Laboratories at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Litron Laboratories takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on genetic toxicology in drug development. It covers in vitro genotoxicity screening with multiplexed biomarkers and automated scoring, plus case studies on applying that testing in practice.

OrganizationACT 2026 Attendance
Litron Laboratories
Rochester, NY
litronlabs.com
Reagent and assay suppliers
Makes flow cytometry kits for genetic toxicology, such as micronucleus and multiplexed in vitro screens, and offers testing services.
Talk
Sun Nov 15
2:00pm–2:30pm
Part of Navigating Genetic Toxicology through Drug Development: Interface of Practice, Strategy, and Regulatory Principles (CE7)
In Vitro Genotoxicity Screening: Demonstrable Value of Multiplexed Biomarkers and Automated Scoring (CE7-3)
Genetic toxicology
Talk
Sun Nov 15
4:00pm–4:30pm
Part of Navigating Genetic Toxicology through Drug Development: Interface of Practice, Strategy, and Regulatory Principles (CE7)
Panel Discussion with Case Studies (CE7-Panel)
Genetic toxicology · with Enveda

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Litron Laboratories

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction